HealthMethenamine Hippurate Lowers Recurrent UTIs but Relapse Rises Post-Treatment
A Norwegian trial found that methenamine hippurate reduces recurrent urinary tract infections in older postmenopausal women. However, the risk of relapse increases after stopping the treatment. This highlights concerns about repeated antibiotic use and antimicrobial resistance in this population.
Business Medical Dialogues·


